{"id":"W4367296836","doi":"10.1212/wnl.0000000000202287","title":"Safety and Clinical Efficacy Outcomes From the Long-term Extension Study of Tolebrutinib in Participants With Relapsing Multiple Sclerosis: 2.5-Year Results (S16.010)","year":2023,"lang":"en","type":"article","venue":"Neurology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Discontinuation; Adverse effect; Expanded Disability Status Scale; Multiple sclerosis; Internal medicine; Upper respiratory tract infection; Physical therapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":{"n_in":0,"stratum":"aff_core","weight":5595.2375,"opus":{"tier":"OUT","genre":"empirical","about_ca":false,"confidence":"high","reason":"Long-term extension results on safety and efficacy of tolebrutinib in relapsing multiple sclerosis; a clinical trial report."},"gpt":{"tier":"OUT","genre":"empirical","about_ca":false,"confidence":"high","reason":"This reports long-term clinical trial safety and efficacy outcomes, not research itself."},"grok":{"tier":"OUT","genre":"empirical","about_ca":false,"confidence":"high","reason":"Clinical long-term safety/efficacy results for tolebrutinib in multiple sclerosis."}}}